Our Company
Presentation
Management Team
Board of directors
Scientific Advisory Board
Contact
Products
Tedopi®
OSE-279
Lusvertikimab (OSE-127)
Pegrizeprument (FR104)
BI 770371
ABBV-230
CLEC-1
Research & Development
Scientific publications
Investors
Press Releases
Regulated information
Financial documents
General Shareholders’ meetings
Partnerships
Pharma partnerships
Clinical partnerships
Academic and public Partnerships
News
Agenda
Press Releases
Contact
en
fr
Catégorie: Non classé
September 2021
Bonjour tout le monde !
January 2019
Article 8
January 2019
Article 9
January 2019
Article 10
January 2019
Article 11
January 2019
Article 12
January 2019
Article 13
January 2019
Article 14
January 2019
Article 15
January 2019
Article 1
1
2
Suivant